Fasken Martineau DuMoulin LLP advised the Underwriter in connection with Medexus Pharmaceuticals’s offering. Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) closed its bought-deal public offering of 3,389,900...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP advised Zeitview in the acquisition. Zeitview took the lead in advanced aerial inspections for energy and infrastructure by acquiring Heliolytics, which specializes...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP advised the sole agent and sole bookrunner. On July 4, 2022, Algernon Pharmaceuticals Inc. (CNSX:AGN) announced the closing of its previously announced marketed...
You must be a Standard 1 Year member to access this content.
Fasken Martineau DuMoulin LLP, Linklaters LLP, Webber Wentzel, Veirano Advogados, Allende & Brea and Larrain y Asociados Ltda. advised Gold Fields Limited. Cassels Brock & Blackwell...
You must be a Standard 1 Year member to access this content.
